A research group from the University of Osaka, Zen University, and the University of Tokyo has mathematically uncovered the ...

Updates in relapsing-remitting MS from ECTRIMS 2025 examine lifestyle interventions, anti-CD20 therapies, efficacy of fenebrutinib, and bone marrow transplantation as an effective long-term treatment.

Panelists discuss how available third-line therapies, such as FTD/TPI, regorafenib, and others, are chosen based on survival ...

Nearly three years after ChatGPT’s launch, the generative artificial intelligence landscape remains in rapid flux. Using high ...

The burden of cognitive decline is growing, affecting many people worldwide and placing a substantial strain on health-care ...